We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Bruker Corp (BRKR) USD0.01

Sell:$66.39 Buy:$66.48 Change: $0.74 (1.10%)
Market closed |  Prices as at close on 21 January 2022 | Switch to live prices |
Change: $0.74 (1.10%)
Market closed |  Prices as at close on 21 January 2022 | Switch to live prices |
Change: $0.74 (1.10%)
Market closed |  Prices as at close on 21 January 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Bruker Corporation is a developer, manufacturer, and distributor of scientific instruments and analytical and diagnostic solutions. The Company operates through four segments: Bruker BioSpin Group, Bruker CALID Group, Bruker Scientific Instruments (BSI) Nano Group and Bruker Energy & Supercon Technologies (BEST). The Bruker BioSpin Group segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The Bruker CALID Group segment designs, manufactures, and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions. The BSI NANO Group segment designs and manufactures advanced X-ray instruments; advanced fluorescence optical microscopy instruments; analytical tools for electron microscopes and X-ray metrology; and defect-detection equipment. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.

Contact details

United States
+1 (978) 6633660

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$10.38 billion
Shares in issue:
151.66 million
Life Sciences Tools & Services
United States
US dollar

Key personnel

  • Frank Laukien
    Chairman of the Board, President, Chief Executive Officer
  • Gerald Herman
    Chief Financial Officer
  • Falko Busse
    President, Bruker BioSpin Group
  • Burkhard Prause
    President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc
  • Juergen Srega
    President of Bruker CALID Group and Bruker Daltonics Division
  • Mark Munch
    Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.